Xenetic Biosciences is a biopharmaceutical company focused on advancing proprietary technology platforms across multiple high-value cancer indications.
Oncology platform aimed at improving immunotherapies by targeting Neutrophil Extracellular Traps (NETs)
Personalized CAR T platform targeting cancers with a patient- and tumor-specific approach.
Our proprietary and patented technologies are being utilized to create life-changing therapies.
May 18, 2022
May 12, 2022
Stay informed about our latest news and updates